Akero Therapeutics Inc header image

Akero Therapeutics Inc

AKRO

Equity

ISIN US00973Y1082 / Valor 48188266

NASDAQ (2024-09-16)
USD 26.77-2.08%

Akero Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Akero Therapeutics Inc is a biopharmaceutical company focused on developing treatments for non-alcoholic steatohepatitis (NASH), a serious liver disease with no approved therapies. The company's main product is efruxifermin (EFX), an engineered protein licensed from Amgen, which is a differentiated Fc-FGF21 fusion protein designed to mimic the biological activity of native FGF21. This protein aims to alleviate cellular stress and regulate metabolism in patients with NASH.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-48.8%1Y
12.1%3Y
40.6%5Y

Performance

118%1Y
99.6%3Y
92.8%5Y

Volatility

Market cap

1898 M

Market cap (USD)

Daily traded volume (Shares)

148,506

Daily traded volume (Shares)

1 day high/low

27.41 / 25.72

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals Inc Valor: 42455144
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 53.94
ADMA Biologics Inc
ADMA Biologics Inc ADMA Biologics Inc Valor: 20794750
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.49%USD 18.09
Performance One AG
Performance One AG Performance One AG Valor: 114548191
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 2.62
CPU Softwarehouse AG
CPU Softwarehouse AG CPU Softwarehouse AG Valor: 4924656
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%EUR 1.00
TC Unterhaltungselektronik AG
TC Unterhaltungselektronik AG TC Unterhaltungselektronik AG Valor: 1124025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%EUR 0.16
Schneider Electric SE
Schneider Electric SE Schneider Electric SE Valor: 509120
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.02%EUR 227.15
Cogent Communications Holdings Inc
Cogent Communications Holdings Inc Cogent Communications Holdings Inc Valor: 1886547
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.98%USD 70.73
Camtek Ltd
Camtek Ltd Camtek Ltd Valor: 1072263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.49%USD 81.13
Plexus Corp
Plexus Corp Plexus Corp Valor: 963299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.33%USD 126.63
Merus N.V.
Merus N.V. Merus N.V. Valor: 32548496
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 50.14